Fintel reports that on January 10, 2025, Needham upgraded their outlook for Collegium Pharmaceutical (NasdaqGS:COLL) from ...
Short interest in Collegium Pharmaceutical Inc (NASDAQ:COLL) decreased during the last reporting period, falling from 6.29M to 6.11M. This put 23.48% of the company's publicly available shares short.
Needham analyst upgrades Collegium Pharmaceutical to Buy with a $46 target, citing strong 2025 guidance, growth potential, ...
Avadel Pharmaceuticals PLC (AVDL) reports significant revenue increase and outlines optimistic projections for 2025 amidst market expansion challenges. DUBLIN, Jan. 06, 2025 (GLOBE NEWSWIRE ...
Supreme Court Seems Poised to Uphold Law That Could Ban TikTok The justices are expected to rule quickly in the case, which pits national security concerns about China against free speech ...
What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,13,041.27 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...